Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies - PubMed (original) (raw)
Review
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou. Pharmacol Rev. 2006 Sep.
Erratum in
- Pharmacol Rev. 2007 Mar;59(1):124
Abstract
The median-effect equation derived from the mass-action law principle at equilibrium-steady state via mathematical induction and deduction for different reaction sequences and mechanisms and different types of inhibition has been shown to be the unified theory for the Michaelis-Menten equation, Hill equation, Henderson-Hasselbalch equation, and Scatchard equation. It is shown that dose and effect are interchangeable via defined parameters. This general equation for the single drug effect has been extended to the multiple drug effect equation for n drugs. These equations provide the theoretical basis for the combination index (CI)-isobologram equation that allows quantitative determination of drug interactions, where CI < 1, = 1, and > 1 indicate synergism, additive effect, and antagonism, respectively. Based on these algorithms, computer software has been developed to allow automated simulation of synergism and antagonism at all dose or effect levels. It displays the dose-effect curve, median-effect plot, combination index plot, isobologram, dose-reduction index plot, and polygonogram for in vitro or in vivo studies. This theoretical development, experimental design, and computerized data analysis have facilitated dose-effect analysis for single drug evaluation or carcinogen and radiation risk assessment, as well as for drug or other entity combinations in a vast field of disciplines of biomedical sciences. In this review, selected examples of applications are given, and step-by-step examples of experimental designs and real data analysis are also illustrated. The merging of the mass-action law principle with mathematical induction-deduction has been proven to be a unique and effective scientific method for general theory development. The median-effect principle and its mass-action law based computer software are gaining increased applications in biomedical sciences, from how to effectively evaluate a single compound or entity to how to beneficially use multiple drugs or modalities in combination therapies.
Similar articles
- Drug combination studies and their synergy quantification using the Chou-Talalay method.
Chou TC. Chou TC. Cancer Res. 2010 Jan 15;70(2):440-6. doi: 10.1158/0008-5472.CAN-09-1947. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068163 - Preclinical versus clinical drug combination studies.
Chou TC. Chou TC. Leuk Lymphoma. 2008 Nov;49(11):2059-80. doi: 10.1080/10428190802353591. Leuk Lymphoma. 2008. PMID: 19021049 Review. - The mass-action law based algorithms for quantitative econo-green bio-research.
Chou TC. Chou TC. Integr Biol (Camb). 2011 May;3(5):548-59. doi: 10.1039/c0ib00130a. Epub 2011 Mar 14. Integr Biol (Camb). 2011. PMID: 21403972 - The mass-action law based algorithm for cost-effective approach for cancer drug discovery and development.
Chou TC. Chou TC. Am J Cancer Res. 2011;1(7):925-54. Epub 2011 Aug 5. Am J Cancer Res. 2011. PMID: 22016837 Free PMC article. - Rational approach to the clinical protocol design for drug combinations: a review.
Chang TT, Chou TC. Chang TT, et al. Acta Paediatr Taiwan. 2000 Nov-Dec;41(6):294-302. Acta Paediatr Taiwan. 2000. PMID: 11198934 Review.
Cited by
- 2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α.
Attia YM, Mokhlis HA, Ismail A, Doghish AS, Sobhy MH, Hassanein SS, El-Dakroury WA, Mariee AD, Salama SA, Sharaky M. Attia YM, et al. Med Oncol. 2024 Aug 21;41(9):232. doi: 10.1007/s12032-024-02471-w. Med Oncol. 2024. PMID: 39167288 Free PMC article. - The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.
Grossman TH, Shoen CM, Jones SM, Jones PL, Cynamon MH, Locher CP. Grossman TH, et al. Antimicrob Agents Chemother. 2015 Mar;59(3):1534-41. doi: 10.1128/AAC.04271-14. Epub 2014 Dec 22. Antimicrob Agents Chemother. 2015. PMID: 25534740 Free PMC article. - Synergistic Neuroprotective Effects of Two Herbal Ingredients via CREB-Dependent Pathway.
Liu X, Wang D, Zhao R, Dong X, Hu Y, Liu P. Liu X, et al. Front Pharmacol. 2016 Sep 27;7:337. doi: 10.3389/fphar.2016.00337. eCollection 2016. Front Pharmacol. 2016. PMID: 27729863 Free PMC article. - Evaluation of the mechanism of action of paracetamol, drotaverine, and peppermint oil and their effects in combination with hyoscine butylbromide on colonic motility: human ex-vivo study.
Traserra S, Barber C, Alcalá-González LG, Landolfi S, Lange R, Malagelada C, Corsetti M, Jimenez M. Traserra S, et al. Front Pharmacol. 2024 Jul 10;15:1384070. doi: 10.3389/fphar.2024.1384070. eCollection 2024. Front Pharmacol. 2024. PMID: 39050750 Free PMC article. - The impact of quercetin and paclitaxel combination on ovarian cancer cells.
Ji H, Zhang Z, Chen C, Xu W, Liu T, Dong Y, Wang J, Wang H, Zhu X. Ji H, et al. iScience. 2024 Jul 1;27(8):110434. doi: 10.1016/j.isci.2024.110434. eCollection 2024 Aug 16. iScience. 2024. PMID: 39108714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources